INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

74,063 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
EA
Edgeworth Jason ADirector
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
4,749 sh
Oct 23, 2026Oct 23, 2026
Page 227 of 1852
← PrevNext →
traded Oct 23, 2026
+0d
SEC Form 4

Evidence

9
BS
Ban Hubert SChief Accounting Officer
CMRCCommerce.com, Inc.
Tax withholding
F$1,405
388 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
RJ
Russo Joseph J.EVP&Pres-Global Networks&Tech
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,104
86 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
SJ
Szkutak Thomas JDirector
INTUINTUIT INC.
Option exercise
M$25K
43 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
TN
Thoma Gina N.EVP, COO
AVBHAvidbank Holdings, Inc.
Grant or award
A—
1,675 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
DL
Dalzell Richard LDirector
INTUINTUIT INC.
Option exercise
M$31K
52 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
SM
Singh Inder MDirector
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A$6,593
122 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
MD
Madaus Martin DInterim CEO
AZTAAzenta, Inc.
Tax withholding
F$47K
1,294 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
MS
Maloney Michael StephenDirector
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
3,999 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

9
AD
Andresen Katherine DunnDirector
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A$2,540
47 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
HT
Hess Christopher TravisDirector, Chief Exec Officer
CMRCCommerce.com, Inc.
Tax withholding
F$12K
3,448 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
MD
Mordell Mark DanielDirector, Pres., CEO
AVBHAvidbank Holdings, Inc.
Grant or award
A—
3,105 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
SJ
Szkutak Thomas JDirector
INTUINTUIT INC.
Option exercise
M—
43 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
DL
Dalzell Richard LDirector
INTUINTUIT INC.
Option exercise
M—
52 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
MN
Madden Karen NDirector
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A$2,972
55 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
LL
Love LoriDirector
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
4,374 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

9
ST
Skiadas Anthony TEVP and CFO
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,738
135 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
SL
Stillwell Mary-LeeSVP and Controller
VZVERIZON COMMUNICATIONS INC
Grant or award
A$585
45 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
HO
Howe OliviaDirector
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
4,749 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

9
WV
Walsh Paul V JrDirector
SMTCSEMTECH CORP
Open-market sale · 10b5-1 plan
SELL$70K
500 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
VA
Villanueva Rodriguez AlfonsoEVP and Group CEO-VZ Consumer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,738
135 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
VV
Venkatesh VandanaEVP and Chief Legal Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,277
99 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
HO
Hemphill Brian ODirector
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A$6,161
114 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
PE
Pershing EdwardDirector, CEO, 10% Owner
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Option exercise
M—
7,599 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

9
GB
Garner John B.Head of Strategy and Vision
WSHPWeShop Holdings Ltd
Option exercise
M—
18.5K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
VA
Valli Todd A.Chief Accounting Officer
FIRYFiry Inc.
Grant or award
A—
10.7K sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

9
LN
Lowenthal Garry NChief Financial Officer
PETVPetVivo Holdings, Inc.
Grant or award
A$6,800
10.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
DM
De Rosch MarkEVP, RA and GA and PgM
CRVOCervoMed Inc.
Grant or award
A—
19.1K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
BK
Blackburn KellyEVP, Clinical Development
CRVOCervoMed Inc.
Grant or award
A—
19.1K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
DC
Dobson David CDirector
WLYWLYBJOHN WILEY & SONS, INC.
Grant or award
A$12K
228 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
LJ
Lai JohnDirector, Chief Executive Officer
PETVPetVivo Holdings, Inc.
Grant or award
A$44K
65.0K sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
WM
Winton MatthewChief Commercial and Business
CRVOCervoMed Inc.
Grant or award
A—
19.1K sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
LM
Lemasney MarkEVP Power Generation Division
NEENEXTERA ENERGY INC
Grant or award
A—
1,416 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC Form 4

Evidence

9
MS
Maloney Michael StephenDirector
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
3,999 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

9
SJ
Sechan II Robert JDirector
BMNRBITMINE IMMERSION TECHNOLOGIES, INC.
Option exercise
M—
4,749 sh
Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence

9
BL
Benedict Tami LauraEVP, Chief of Staff
AVBHAvidbank Holdings, Inc.
Grant or award
A—
1,205 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
CD
Cassidy Charles DGeneral Counsel and Secretary
CMRCCommerce.com, Inc.
Tax withholding
F$1,470
406 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

9
BE
Burwig Susan EExec. VP, Operations
MEDPMedpace Holdings, Inc.
Option exercise
M—
2,700 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
GS
Gheuens SarahChief Medical Officer
AGIOAGIOS PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$56K
1,489 sh
Oct 21, 2026Oct 23, 2026
traded Oct 21, 2026
+2dSEC Form 4

Evidence

8
PE
Pershing EdwardDirector, CEO, 10% Owner
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Option exercise
M—Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC Form 4

Evidence